RIPK3 and colorectal carcinoma: This further corroborates other findings by Feng et al. [94], who found that RIPK3 expression is considerably lower in CRC and associated with the primary tumor (T stage), the presence of distant metastasis (M stage), and the American Joint Committee on Cancer (AJCC stage) of CRC.